$PMCB September 14, 2018, CRO Meeting with 1 of the 2 Final Candidates - PharmaCyte CEO, Ken Waggoner, Principal Investigator, Dr. Manuel Hidalgo, and Chief Medical Officer, Dr. Linda Sher in attendance. https://www.facebook.com/pharmacytebiotech/
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.